Janux Therapeutics (JANX) Price to Sales (2021 - 2026)
Janux Therapeutics' (JANX) Price to Sales was 39.09 for Q2 2026, down 98.7% from 3120.23 a year earlier and down 36.5% from the prior quarter.
Powered by 
Analysis
Janux Therapeutics (JANX) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025, Price to Sales at Janux Therapeutics was 83.33, down 72.1% from FY2024.
- By year, Price to Sales came in at 298.67 in FY2024 (+386.4%), 61.40 in FY2023 (-3.5%), 63.64 in FY2022 (-50.1%) and 127.65 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Price to Sales in data going back to Q2 2021.
- Year over year, Price to Sales has now declined in each of the last four quarters, with growth averaging 46.8% over the last seven quarters.
- The high point for year-over-year Price to Sales in five years was Q4 2024 (growth of 386.4%); the low point was Q2 2026 (a decline of 98.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 61.61 (Q1 2026), 83.33 (Q4 2025) and 146.94 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Janux Therapeutics | 1.04 Bn | 1.04 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.09 |
| Mar 31, 2026 | 61.61 |
| Dec 31, 2025 | 83.33 |
| Sep 30, 2025 | 146.94 |
| Jun 30, 2025 | 3,120.23 |
| Mar 31, 2025 | 171.12 |
| Dec 31, 2024 | 298.67 |
| Sep 30, 2024 | 182.21 |
| Jun 30, 2024 | 144.45 |
| Mar 31, 2024 | 267.85 |
| Dec 31, 2023 | 61.40 |
| Sep 30, 2023 | 54.94 |
| Jun 30, 2023 | 64.02 |
| Mar 31, 2023 | 55.76 |
| Dec 31, 2022 | 63.64 |
| Sep 30, 2022 | 76.20 |
| Jun 30, 2022 | 75.31 |
| Mar 31, 2022 | 122.49 |
| Dec 31, 2021 | 127.65 |
| Sep 30, 2021 | 440.65 |
API Access
Janux Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();